Liane Hornsey
Known title: DirectorCIK: 0002018790
Liane Hornsey's purchase track record
Liane Hornsey has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/12/2024 | CDLX | $36K | +29.3% | -7.1% | +13.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CDLX | ▲ Buy | Option Exercise | 11,000 | $0 | 5/20/2026 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 11,000 | — | 5/23/2025 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 1,326 | — | 4/9/2025 | View on chart |
| CDLX | ▲ Buy | Open Market | 10,000 | $36K | 8/12/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
CDLX: No company news in last 7 days
The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.
CDLX: No company news in last 7 days. The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.